2013 – #183 – BioSyent Inc.

Licenses prescription drugs and markets them to wholesalers for sale to pharmacies or hospitals. A key growth driver is FeraMAX, an oral iron supplement that lacks the often unpleasant side effects of rival products.

 

Company Profile

Founded 1992
Chief Executives Rene Goehrum
Head Office Toronto
Website www.biosyent.com
Stock Ticker TSXV: RX

 

Company Financials

5-Year Growth (%) 355
Reporting Curency CAD
Exports as % of Sales 2
Employees 2012 18
Revenue 2012 ($): 5,024,154

Comparison

Pharmaceuticals & nutraceuticals (manufacturing & distribution) indusrty 4/7
Region 66/187

 

Read More

Comments are closed.